logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lorraine Blaise

avicenne hospital
H指数:14
被引数:738

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience

整合性和交互式基因组分析指导个性化联合疗法改善转移性患者的临床获益：一项单中心真实世界经验

BIOMEDICINE & PHARMACOTHERAPY
IF7.5
2026-04-290
OAAI
Jelena Filipovic; Emma Anjorand; Laetitia Marisa; Eurydice Angeli; Claire Davoine; Hélène Blons; Karen Leroy; Jaqueline Lehmann-Che; Frédéric Pamoukdjian; Lorraine Blaise; Amal Ait-Omar; Nicolas Derive; Antoine Martin; Géraldine Falgarone; Marianne Ziol; Michael Soussan; Jacques Cadranel; Pierre Laurent-Puig; Guilhem Bousquet; Diaddin Hamdan
Frailty assessed using the Liver Frailty IndexTM (LFI) is a risk factor for mortality in patients with advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab

使用Liver Frailty IndexTM（LFI）评估的虚弱是接受阿替利珠单抗-贝伐珠单抗治疗的晚期肝细胞癌患者的死亡风险因素。

HEPATOBILIARY SURGERY AND NUTRITION
IF7.8
2025-12-010
PRE
Sultanik, Philippe; Campani, Claudia; Mouri, Sarah; Spitzer, Eleonore; Wagner, Mathilde; Blaise, Lorraine; Lequoy, Marie; Ozenne, Violaine; Nault, Jean Charles; Thabut, Dominique; Ganne-Carrie, Nathalie; Allaire, Manon
Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma

免疫疗法后肝移植在肝细胞癌患者中的可行性与有效性

LIVER CANCER
IF9.1
2025-12-010
OA
Amaddeo, Giuliana; Allaire, Manon; Franze, Maria Stella; Dupre, Clement; Caruso, Stefano; Antonini, Teresa; Chouik, Yasmina; Regnault, Helene; Beaufrere, Aurelie; Ursic-Bedoya, Jose; Ningarhari, Massih; Uguen, Thomas; Jaillais, Anais; Roux, Olivier; Blaise, Lorraine; Gerolami, Rene; Pascale, Alina; Brustia, Raffaele; Sommacale, Daniele; Dumortier, Jerome; Leroy, Vincent
COVID-19 and chronic liver disease: results from the 1219 patients French registry

COVID-19与慢性肝病：来自1219名患者法国登记研究的结果

Scientific Reports
IF3.9
2025-10-070
OA
L. Blaise; F. Lebossé; C. Costentin; S. Si Ahmed; A. Heurgué; H. Fontaine; M. Meszaros; S. Radenne; C. Vanlemmens; A. Landrieux; C. Bouzbib; H. Barraud; E. Bardou-Jacquet; O. Chazouillères; M. Latournerie; I. Rosa; R. Anty; M. Gelu-Simeon; M. Khaldi; G. Amaddeo; C. Lemaitre; B. Bernard-Chabert; L. Moga; D. Roulot-Marullo; L. Elkrief; J. Boursier; A. Plessier; C. Bureau; G.-P. Pageaux; A. J. Rémy; P. Sultanik; V. de Ledinghen; N. Reboux; F. Texier; J.-B. Hiriart; H. Montialoux; S. de Montigny; M. Rudler; N. Williet; Z. Talib; B. Mboup; M. Bourlière; E. Vicaut; N. Ganne-Carrié; J. Dumortier
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study

阿替利珠单抗和贝伐珠单抗联合或联合TACE作为不可切除性HCC的一线治疗的疗效和安全性：一项多中心队列研究

Hepatology International
IF6.1
2025-08-250
PRE
Ningning Zhang; Kaipeng Liu; Yuexi Yu; Kai Yuan; Haipeng Yu; Jean Charles Nault; Claudia Campani; Lorraine Blaise; Sara Mouri; Eleonore Spitzer; Yawei Du; Shuwen Zhang; Wenwen Zhu; Hao Yu; Tian Liu; Xuanchen Liu; Ming Luo; Huiru Liu; Yiyan Zhang; Yiming Huo; Feng Duan; Manon Allaire; Wei Lu; Jihui Hao
The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment

早期MRI在评估不可逆电穿孔治疗肝细胞癌后局部肿瘤进展风险中的作用

International Journal of Hyperthermia
IF3
2025-05-280
OA
Lorenzo Carlo Pescatori; Mathilde Dessain; Gisèle N’Kontchou; Arthur Petit; Abou Diallo; Lorraine Blaise; Marie-Pierre Rols; Clair Poignard; Jean-Charles Nault; Nathalie Ganne-Carrié; Pierre Nahon; Olivier Sutter; Olivier Seror
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

经皮射频消融治疗肝细胞癌期间肿瘤和非肿瘤活检的应用价值

JHEP Reports
IF7.5
2025-04-220
OAAI
Lorraine Blaise; Marianne Ziol; Claudia Campani; Nathalie Ganne-Carrie; Pierre Nahon; Gisele Nkontchou; Jessica Zucman-Rossi; Lucie Del Pozo; Nathalie Barget; Carina Boros; Elvire Desjonqueres; Alix Demory; Veronique Grando; Lorenzo Pescatori; Olivier Seror; Olivier Sutter; Jean-Charles Nault
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
ANNALS OF HEPATOLOGY
IF4.4
2023-11-011
OAAI
Brustia, Raffaele; Bouattour, Mohamed; Allaire, Manon; Lequoy, Marie; Hollande, Clemence; Regnault, Helene; Blaise, Lorraine; Ganne-Carrie, Nathalie; Vilgrain, Valerie; Larrey, Edouard; Lim, Chetana; Scatton, Olivier; El Mouhadi, Sanaa; Ozenne, Violaine; Paye, Francois; Balladur, Pierre; Dohan, Anthony; Massault, Pierre-Philippe; Pol, Stanislas; Burgio, Marco Dioguardi; Sepulveda, Ailton; Cauchy, Francois; Luciani, Alain; Sommacale, Daniele; Leroy, Vincent; Calderaro, Julien; Roudot-Thoraval, Francoise; Nault, Jean-Charles; Amaddeo, Giuliana
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors

多激酶抑制剂治疗失败后，阿特珠单抗联合贝伐单抗治疗晚期肝细胞癌

DIGESTIVE AND LIVER DISEASE
IF3.8
2023-07-014
OAAI
Haghnejad, Vincent; Muller, Marie; Blaise, Lorraine; Gerolami, Rene; Bouattour, Mohamed; Assenat, Eric; Manfredi, Sylvain; Peron, Jean-Marie; Burcheri-Curatolo, Adriano; Lopez, Anthony; Ressiot, Emmnanuelle; Nahon, Pierre; Bronowicki, Jean-Pierre

研究方向

暂未获取到该数据
N
Nathalie Ganne‐Carrié
H 指数:60论文数:433被引数:1.4万
J
Jean‐Charles Nault
H 指数:63论文数:369被引数:1.9万
P
Pierre Nahon
H 指数:58论文数:366被引数:1.3万
M
Manon Allaire
H 指数:22论文数:149被引数:1,746
O
Olivier Séror
H 指数:35论文数:220被引数:5,439
O
Olivier Sutter
H 指数:17论文数:80被引数:1,448
M
Marianne Ziol
H 指数:51论文数:318被引数:1.4万
G
G. Nkontchou
H 指数:32论文数:127被引数:4,948
C
Claudia Campani
H 指数:20论文数:152被引数:1,422
A
Alix Demory
H 指数:7论文数:23被引数:142